To Study the Prevalence of Insomnia in Geriatric COPD Patients Who Are Enrolled in a Pulmonary Rehabilitation Program.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Hackensack University Medical Center
ClinicalTrials.gov Identifier:
NCT00346554
First received: June 28, 2006
Last updated: February 1, 2014
Last verified: February 2014
  Purpose

The goal for COPD patients in pulmonary rehabilitation programs is to improve the quality of life. COPD is known to be worse at night as are other respiratory problems such as CHF. Saturation is known to get worse nocturnally as well. Furthermore, these COPD rehabilitation patients tend to be older and increasing age is associated with an increase in the incidence of sleep disorders. We suspect that there is an increase in the incidence of sleep disorders in COPD patients. We plan to further study these patients using questionnaires. A preliminary study was done, but the results were not comparable to national statistics. We plan to repeat the study, only changing the questions to a format comparable to data from the National Sleep Foundation.


Condition
COPD
Sleep Disorders

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: To Study the Prevalence of Insomnia in Geriatric COPD Patients Who Are Enrolled in a Pulmonary Rehabilitation Program.

Resource links provided by NLM:


Further study details as provided by Hackensack University Medical Center:

Enrollment: 50
Study Start Date: April 2006
Study Completion Date: May 2008
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   60 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Greitric COPD patients who are enrolled in Pulmonary Rehabilitation at HUMC

Criteria

Inclusion Criteria:

  • COPD
  • rehabilitation program
  • FEV1<60%

Exclusion Criteria:

  • FEV1>60%
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00346554

Locations
United States, New Jersey
Hackensack University Medical Center - Pulmonary Rehabilitation
Hackensack, New Jersey, United States, 07601
Sponsors and Collaborators
Hackensack University Medical Center
Investigators
Principal Investigator: Hormoz Ashtyani, MD Hackensack University Medical Center
Principal Investigator: Susan Zafarlotfi, Ph.D Hackensack University Medical Center
  More Information

No publications provided

Responsible Party: Hackensack University Medical Center
ClinicalTrials.gov Identifier: NCT00346554     History of Changes
Other Study ID Numbers: 06.01.008
Study First Received: June 28, 2006
Last Updated: February 1, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Hackensack University Medical Center:
COPD
Sleep disorders
pulmonary rehabilitation

Additional relevant MeSH terms:
Pulmonary Disease, Chronic Obstructive
Sleep Disorders
Parasomnias
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Diseases
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Mental Disorders

ClinicalTrials.gov processed this record on July 22, 2014